Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 6/20 | 0.48 |
| ▸ | CA2 | P00918 | 6/20 | 0.48 |
| ▸ | CA9 | Q16790 | 6/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.44 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 3/20 | 0.39 |
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | ADRB2 | P07550 | 2/20 | 0.33 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.33 |
| ▸ | HTR1A | P08908 | 1/20 | 0.33 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1595637 | 0.83 | CYP3A4 (0.55) | CA1CA2CA9CYP1A2CYP2C9 | |
| SCHEMBL1596755 | 0.83 | GAA (0.55) | CA1CA2CA9CYP1A2CYP2C9 | |
| SCHEMBL7147396 | 0.77 | ADRB1 (0.45) | CA1CA2CA9ALOX15HIF1A | |
| SCHEMBL31424216 | 0.73 | CA1 (0.54) | CA1CA2CA9CYP1A2HIF1A | |
| SCHEMBL525650 | 0.73 | CYP3A4 (0.65) | CA1CA2CA9GAAMAPT | |
| SCHEMBL31050390 | 0.73 | CA1 (0.54) | CA1CA2CA9HSD17B10GAA | |
| SCHEMBL9772902 | 0.73 | CA1 (0.54) | CA1CA2CA9GAAMAPT | |
| SCHEMBL6217810 | 0.73 | CA1 (0.54) | CA1CA2CA9CYP1A2HIF1A | |
| SCHEMBL3605101 | 0.73 | CA1 (0.54) | CA1CA2CA9HSD17B10GAA | |
| SCHEMBL1596630 | 0.73 | HSD17B10 (0.70) | CA1CA2CYP1A2CYP2C9ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1780224-B1 | MULTIBRANCHED POLYMERS AND PROCESS FOR PRODUCTION THEREOF | NIPPON SODA CO (JP) | 2015-02-18 | — | — | EP | disclosed |
| US-8710165-B2 | Multibranched polymer and method for producing the same | NIPPON SODA CO., LTD. (JP) | 2014-04-29 | — | — | US | disclosed |
| US-20110152388-A1 | Multibranched polymer and method for producing the same | NIPPON SODA CO., LTD. (JP) | 2011-06-23 | — | — | US | disclosed |
| US-7919570-B2 | narrowly dispersed; controlled molecular weight; ionic conductivity, shape stability; battery adhesive or binder; 1,1,2,2-tetrakis(4-hydroxyphenyl)ethane or pentaerythritol reacted with bromoisobutyroyl bromide for core; living radical polymerization of acrylate or a styrene at halogen atoms as the arms | NIPPON SODA CO., LTD. (JP) | 2011-04-05 | — | — | US | disclosed |
| US-7601784-B2 | 1,1,2,2-tetrakis(4-hydroxyphenyl)ethane is used to molecular alignment, chemical stabilization, heat resist, flexiable and modification of the polyether having hydrogen bond sites; for waste water treatments, energy transducers, conductors | NIPPON SODA CO., LTD. (JP) | 2009-10-13 | — | — | US | disclosed |
| US-20080214685-A1 | Multibrached Polymer and Method for Producing the Same | NIPPON SODA CO., LTD. (JP) | 2008-09-04 | — | — | US | disclosed |
| EP-1792947-A1 | Molecular compound comprising polymer having hydrogen bond as component compound | NIPPON SODA CO., LTD. (JP) | 2007-06-06 | — | — | EP | disclosed |
| EP-1780224-A1 | MULTIBRANCHED POLYMERS AND PROCESS FOR PRODUCTION THEREOF | NIPPON SODA CO., LTD. (JP) | 2007-05-02 | — | — | EP | disclosed |
| US-20050228167-A1 | Molecular compounds containing polymers having hydrogen bond sites as the constituent compounds | NIPPON SODA CO., LTD. (JP) | 2005-10-13 | — | — | US | disclosed |
| US-20020193528-A1 | Molecular compound comprising polymer having hydrogen bond as component compound | NIPPON SODA CO., LTD. (JP) | 2002-12-19 | — | — | US | disclosed |
| EP-1241230-A1 | MOLECULAR COMPOUND COMPRISING POLYMER HAVING HYDROGEN BOND AS COMPONENT COMPOUND | NIPPON SODA CO., LTD. (JP) | 2002-09-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020193528-A1 | Molecular compound comprising polymer having hydrogen bond as component compound | PIEZO1, PARN, PARG | CA1 2814/4885CA2 1953/4885CA9 4446/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.